Scheduled maintenance is planned from Friday, Nov. 6, through Saturday, Nov. 7. You will experience intermittent outages during this time.

Making confident cancer screening decisions in primary care

Provided by AAFP partner
A woman looks at a computer screen in a lab.

The cancer screening landscape continues to evolve, with an increasing number of screening options offering different capabilities and limitations. In this six-part video series, experts in primary care, gastroenterology, and cancer screening discuss practical considerations to help patients make informed screening decisions—from colorectal cancer (CRC) screening to emerging multi-cancer early detection (MCED) approaches.

  • CRC burden, screening gaps, and guidelines
    CRC remains a significant health burden, including among younger adults. The discussion reviews current CRC screening gaps and recommendations to begin screening at age 45.
  • Selecting the right CRC screening test
    When considering a non-invasive screening test, patient preference can play an important role in adherence. The experts discuss balancing patient preference with test performance.
  • Stool-based screening and Cologuard Plus
    Learn about stool-based CRC screening modalities and how the Cologuard Plus test combines DNA markers with a hemoglobin assay. The discussion explores CRC and precancer sensitivity, specificity, and the need for colonoscopy following a positive test.
  • Overcoming barriers to CRC screening
    Ordering a screening test does not always translate into completion. The experts discuss barriers including scheduling, bowel preparation, transportation, and time away from work, as well as patient navigation and non-invasive screening workflows that may help facilitate screening completion.
  • Blood-based CRC screening
    Blood-based testing adds another option to the CRC screening landscape. The discussion considers differences among screening approaches, including limitations of current blood-based tests in detecting precancerous lesions and early-stage cancers, and circumstances in which blood-based testing may be considered.
  • Multi-cancer early detection in primary care
    The final discussion moves beyond single-organ screening to multi-cancer early detection. The experts explore patient interest in MCED, the role of these tests alongside established screening, the interpretation of positive and negative results, and considerations for diagnostic follow-up.

References

Full citations supporting the clinical and scientific information presented above are provided within the videos.

Disclaimer:
The posting of information and content on this page should not be considered an AAFP endorsement or recommendation of the partner or sponsor organization’s products, services, policies or procedures. The information and opinions expressed are those of partners and paid sponsors and do not necessarily reflect the views of the AAFP. The AAFP is not responsible for the content of third-party websites linked from this page. Any links on this page to third-party websites where goods and services are advertised are not endorsements or recommendations by the AAFP of the third-party sites, goods or services.